Evaluation of in vitro antiviral activity against different SARS-CoV-2 variants of a protease PROTAC degrader

Elena Lenci; Andrea Trabocchi; Stefano Rusconi; Mirko Giuseppe Liturri; Annalisa Bergna; Alessia Lai; Carla Aparecida Arena Ventura; Arianna Gabrieli; Ioana Seravalli; Simone Ciofi‐Baffoni

doi:10.1016/j.phrs.2025.108063

Affiliated Institutions

Related Publications

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Wenhao Dai , Bing Zhang , Xia-Ming Jiang +24 more

Promising antiviral protease inhibitors With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find...

2020 Science 1546 citations

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen , Charlotte Allerton , Annaliesa S. Anderson +40 more

Path to another drug against COVID-19 The rapid development of vaccines has been crucial in battling the ongoing COVID-19 pandemic. However, access challenges remain, breakthrou...

2021 Science 1754 citations

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai , Kiyoko Iwatsuki‐Horimoto , Masato Hatta +31 more

Significance Since SARS-CoV-2 emerged in China, it has spread rapidly around the world. Effective vaccines and therapeutics for SARS-CoV-2−induced disease (coronavirus disease 2...

2020 Proceedings of the National Academy o... 1134 citations

Mode of Inhibition of Respiratory Syncytial Virus by a Plant Flavonoid, SP-303

Dale L. Barnard , John H. Huffman , Laurence R. Meyerson +1 more

A natural-product polyphenolic polymer of molecular weight 2,100 daltons designated SP-303, was found to have antiviral activity against respiratory syncytial virus (RSV) in the...

1993 Chemotherapy 39 citations

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan , Amy Sims , Sarah R. Leist +16 more

Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 death...

2020 Nature Communications 1785 citations

Publication Info

Year: 2025
Type: letter
Volume: 223
Pages: 108063-108063
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Evaluation of in vitro antiviral activity against different SARS-CoV-2 variants of a protease PROTAC degrader

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Elena Lenci, 
                                
                                    Andrea Trabocchi, 
                                
                                    Stefano Rusconi
                                
                                et al.
                            
                            (2025). 
                            Evaluation of in vitro antiviral activity against different SARS-CoV-2 variants of a protease PROTAC degrader. 
                            Pharmacological Research
                            , 223
                            
                            , 108063-108063.
                            https://doi.org/10.1016/j.phrs.2025.108063

Identifiers

DOI: 10.1016/j.phrs.2025.108063